John Mark Sloan: Clinical Trials

1 trial sponsored by John Mark Sloan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow John Mark Sloan: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Idelalisib for Immunoglobulin M (IgM)-Associated Primary (AL) Amyloidosis
Idelalisib - Amyloidosis
Phase 2TerminatedJohn Mark Sloan12016-01-012017-09-21

Conditions studied

Amyloidosis (1)

Interventions

idelalisib (1)

Countries

United States (1)